Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DDY51F
|
|||
| Drug Name |
EDP-514
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Chronic HBV infection [ICD-11: 1E51.0Z] | Phase 1 | [1] | |
| Company |
Enanta Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Capsid protein (HBV C) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04470388) A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Enanta Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.